We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
+8.38%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$3.74B
AUM Growth
-$335M
(-8.2%)
Cap. Flow
-$614M
Cap. Flow
% of AUM
-16.42%
Top 10 Holdings %
Top 10 Hldgs %
21.69%
Holding
674
New
53
Increased
215
Reduced
238
Closed
121
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$113M |
| 2 |
Intel
INTC
|
+$61.2M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$25.3M |
| 4 |
Clorox
CLX
|
+$25.2M |
| 5 |
TJX Companies
TJX
|
+$24.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$107M |
| 2 |
Apple
AAPL
|
+$71.8M |
| 3 |
Travelers Companies
TRV
|
+$27.6M |
| 4 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$27.4M |
| 5 |
American Express
AXP
|
+$26.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 28.7% |
| 2 | Financials | 10.88% |
| 3 | Technology | 9.76% |
| 4 | Communication Services | 9.34% |
| 5 | Consumer Staples | 9.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Intuitive Surgical
ISRG
$121B
| $1.8M | 0.05% |
29,691
-7,920
| -21% | -$445K |
|
|
DO
302
DELISTED
Diamond Offshore Drilling
DO
| $1.78M | 0.05% |
+84,569
| New | +$1.78M |
|
303
Intuit
INTU
$81.1B
| $1.77M | 0.05% |
18,359
+3,173
| +21% | +$307K |
|
304
Labcorp
LH
$24.3B
| $1.76M | 0.05% |
16,618
-116,019
| -87% | -$12M |
|
|
TGNA
305
DELISTED
TEGNA Inc
TGNA
| $1.76M | 0.05% |
107,598
-209,777
| -66% | -$3.55M |
|
306
Vulcan Materials
VMC
$36.3B
| $1.75M | 0.05% |
18,384
-161
| -0.9% | -$15.6K |
|
307
Manulife Financial
MFC
$72.6B
| $1.74M | 0.05% |
116,731
-6,550
| -5% | -$106K |
|
|
DD
308
DELISTED
Du Pont De Nemours E I
DD
| $1.71M | 0.05% |
25,731
+1,879
| +8% | +$119K |
|
309
Zimmer Biomet
ZBH
$17.7B
| $1.71M | 0.05% |
17,135
-112,941
| -87% | -$11.1M |
|
|
RTN
310
DELISTED
Raytheon Company
RTN
| $1.7M | 0.05% |
13,658
-1,609
| -11% | -$193K |
|
|
ZGNX
311
DELISTED
Zogenix, Inc.
ZGNX
| $1.68M | 0.04% |
113,900
| – | – |
|
|
ESPR
312
DELISTED
Esperion Therapeutics
ESPR
| $1.67M | 0.04% |
75,000
-25,800
| -26% | -$651K |
|
|
TCON
313
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
| $1.66M | 0.04% |
900
+223
| +33% | +$446K |
|
314
NextEra Energy
NEE
$187B
| $1.66M | 0.04% |
63,996
+10,748
| +20% | +$272K |
|
|
KDNY
315
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $1.64M | 0.04% |
11,676
-54
| -0.5% | -$7.33K |
|
316
Kraft Heinz
KHC
$30.4B
| $1.59M | 0.04% |
21,881
-29,499
| -57% | -$2.18M |
|
317
Northrop Grumman
NOC
$77B
| $1.59M | 0.04% |
8,418
-73,791
| -90% | -$13.5M |
|
318
NOV
NOV
$7.45B
| $1.59M | 0.04% |
47,414
-229,438
| -83% | -$8.53M |
|
319
Deere & Co
DE
$170B
| $1.58M | 0.04% |
20,774
-467
| -2% | -$36.1K |
|
320
Duke Energy
DUK
$102B
| $1.58M | 0.04% |
22,189
+2,423
| +12% | +$170K |
|
321
Equifax
EFX
$20.3B
| $1.56M | 0.04% |
14,020
+1,081
| +8% | +$117K |
|
|
FLIR
322
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
| $1.53M | 0.04% |
+54,625
| New | +$1.55M |
|
|
LVLT
323
DELISTED
Level 3 Communications Inc
LVLT
| $1.52M | 0.04% |
27,935
-3,816
| -12% | -$191K |
|
324
Morgan Stanley
MS
$337B
| $1.51M | 0.04% |
47,410
+269
| +0.6% | +$8.94K |
|
|
CALA
325
DELISTED
Calithera Biosciences, Inc
CALA
| $1.49M | 0.04% |
9,750
| – | – |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q4 2015 Portfolio in Review
As of Q4 2015, Candriam SCA held 674 positions worth $3.74B, down 8.2% from $4.07B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Candriam SCA withdrew a net $614M in Q4 2015, closing 121 positions and reducing 238 holdings. Its most notable exit was Amgen, an estimated $107M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 29% a quarter earlier, followed by Financials and Technology.
Against the trend, Candriam SCA opened a new position in Alphabet (Google) Class A worth $118M.
- Candriam SCA's largest Q4 2015 buy was Alphabet (Google) Class A: 3,043,280 shares worth $118M.
- Candriam SCA added most to Intel in Q4 2015, an estimated $61.2M increase.
- Candriam SCA's biggest Q4 2015 reduction was Colgate-Palmolive, cutting an estimated $21.3M.
- Candriam SCA fully exited Amgen in Q4 2015, selling an estimated $107M.
- Candriam SCA's ten largest holdings make up 22% of its $3.74B portfolio in Q4 2015.
- Candriam SCA opened 53 new positions and closed 121 in Q4 2015.
- Candriam SCA's portfolio value fell 8.2% quarter-over-quarter to $3.74B.
Based on Candriam SCA's 13F filing for Q4 2015, filed 25 Jan 2016.